| Submission | 12 Months Ended |
| Dec. 31, 2024 | |
| Submission [Line Items] | |
| Central Index Key | 0001601830 |
| Registrant Name | Recursion Pharmaceuticals, Inc. |
| Registration File Number | 333-264845 |
| Form Type | S-3 |
| Submission Type | 424B7 |
| Fee Exhibit Type | EX-FILING FEES |
| Offerings - Offering: 1 | Dec. 13, 2024 USD ($) shares |
| Offering: | |
| Fee Previously Paid | false |
| Other Rule | true |
| Security Type | Equity |
| Security Class Title | Class A Common Stock, par value $0.00001 per share |
| Amount Registered | shares | 3,498,393 |
| Proposed Maximum Offering Price per Unit | 6.945 |
| Maximum Aggregate Offering Price | $ 24,296,339.39 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 3,719.77 |
| Offering Note | Includes an indeterminate number of additional shares of Class A common stock, par value $0.00001 per share (the “Class A common stock”) of Recursion Pharmaceuticals, Inc. (“Recursion”) that, pursuant to Rule 416 under the Securities Act of 1933, as amended, or the Securities Act, may be issued to prevent dilution from stock splits, stock dividends or similar transactions. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, based upon the average of the high and low prices of the Class A common stock on the Nasdaq Global Select Market on December 13, 2024. |
| Fees Summary | Dec. 13, 2024 USD ($) |
| Fees Summary [Line Items] | |
| Total Offering | $ 24,296,339.39 |
| Previously Paid Amount | 0 |
| Total Fee Amount | 3,719.77 |
| Total Offset Amount | 0 |
| Net Fee | $ 3,719.77 |
